Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
7013.T Stock Summary
Top 10 Correlated ETFs
7013.T
In the News
7013.T Financial details
Company Rating
Buy
Market Cap
583.22B
Income
-92.1B
Revenue
1273.22B
Book val./share
2100.79
Cash/share
832.28
Dividend
100
Dividend %
3.57%
Employees
28.49K
Optionable
No
Shortable
Yes
Earnings
05 Feb 2024
P/E
-3.71
Forward P/E
-
PEG
0.16
P/S
0.34
P/B
1.42
P/C
4.53
P/FCF
-4.99
Quick Ratio
0.62
Current Ratio
1.1
Debt / Equity
2.72
LT Debt / Equity
1.03
-
-
EPS (TTM)
-608.8
EPS next Y
-
EPS next Q
-
EPS this Y
-33.04%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
2.64%
Revenue last 5Y
-1.82%
Revenue Q/Q
130.63%
EPS Q/Q
-119.53%
-
-
-
-
SMA20
7.37%
SMA50
37.76%
SMA100
34.44%
Inst Own
-
Inst Trans
-
ROA
-6%
ROE
-29%
ROC
-0.11%
Gross Margin
9%
Oper. Margin
-9%
Profit Margin
-9%
Payout
-12%
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
2480.0-4156.0
52W High
-9.24%
52W Low
+52.1%
RSI
51
Rel Volume
1.12
Avg Volume
2.69M
Volume
3.01M
Perf Week
0.37%
Perf Month
3.94%
Perf Quarter
36.3%
Perf Half Y
27.6%
-
-
-
-
Beta
1.566
-
-
Volatility
53.74%, 185.39%
Prev Close
0.43%
Price
3772
Change
-0.82%
7013.T Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2023-03-31
Metric | History | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 | 2023-03-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 9.61K | 9.11K | 7.49K | 7.81K | 8.94K | |
Net income per share | 258.37 | 84.19 | 88.13 | 439.74 | 294.44 | |
Operating cash flow per share | 300.56 | 95.35 | 244.88 | 759.83 | 357.71 | |
Free cash flow per share | -117.79 | -340.68 | -141.88 | 456.48 | -55.93 | |
Cash per share | 630.18 | 967.65 | 822.26 | 989.64 | 853.46 | |
Book value per share | 2.27K | 2.15K | 2.02K | 2.54K | 2.85K | |
Tangible book value per share | 2.25K | 2.11K | 1.35K | 1.86K | 2.16K | |
Share holders equity per share | 2.27K | 2.15K | 2.02K | 2.54K | 2.85K | |
Interest debt per share | 2.3K | 3.2K | 4.11K | 3.4K | 3.51K | |
Market cap | 417.46B | 192.04B | 333.52B | 443.2B | 502.27B | |
Enterprise value | 674.42B | 527.72B | 818.69B | 803.27B | 897.01B | |
P/E ratio | 10.47 | 14.99 | 25.47 | 6.71 | 11.28 | |
Price to sales ratio | 0.28 | 0.14 | 0.3 | 0.38 | 0.37 | |
POCF ratio | 9 | 13.23 | 9.17 | 3.88 | 9.28 | |
PFCF ratio | -22.96 | -3.7 | -15.82 | 6.46 | -59.36 | |
P/B Ratio | 1.19 | 0.59 | 1.11 | 1.16 | 1.16 | |
PTB ratio | 1.19 | 0.59 | 1.11 | 1.16 | 1.16 | |
EV to sales | 0.45 | 0.38 | 0.74 | 0.68 | 0.66 | |
Enterprise value over EBITDA | 5.16 | 5.28 | 7.25 | 4.55 | 6.1 | |
EV to operating cash flow | 14.53 | 36.37 | 22.5 | 7.04 | 16.58 | |
EV to free cash flow | -37.08 | -10.18 | -38.84 | 11.71 | -106.02 | |
Earnings yield | 0.1 | 0.07 | 0.04 | 0.15 | 0.09 | |
Free cash flow yield | -0.04 | -0.27 | -0.06 | 0.15 | -0.02 | |
Debt to equity | 1.01 | 1.48 | 2.01 | 1.32 | 1.2 | |
Debt to assets | 0.21 | 0.28 | 0.33 | 0.27 | 0.27 | |
Net debt to EBITDA | 1.97 | 3.36 | 4.3 | 2.04 | 2.69 | |
Current ratio | 1.2 | 1.18 | 1.24 | 1.32 | 1.31 | |
Interest coverage | 25.56 | 15.34 | 5.48 | 17.62 | 7.34 | |
Income quality | 0.67 | 0.37 | 1.32 | 1.3 | 0.83 | |
Dividend Yield | 0.02 | 0.06 | 0.01 | 0.01 | 0.02 | |
Payout ratio | 0.23 | 0.84 | 0.23 | 0.07 | 0.27 | |
Sales general and administrative to revenue | 0.08 | 0.09 | 0.15 | 0.15 | 0.15 | |
Research and developement to revenue | 0.02 | 0.03 | 0.02 | 0.02 | 0.03 | |
Intangibles to total assets | 0.02 | 0.02 | 0.07 | 0.07 | 0.07 | |
Capex to operating cash flow | -1.39 | -4.57 | -1.58 | -0.4 | -1.16 | |
Capex to revenue | -0.04 | -0.05 | -0.05 | -0.04 | -0.05 | |
Capex to depreciation | -1.05 | -1.02 | -0.72 | -0.54 | -0.88 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 3.63K | 2.02K | 2K | 5.02K | 4.35K | |
ROIC | 0.08 | 0.03 | 0.02 | 0.06 | 0.06 | |
Return on tangible assets | 0.02 | 0.01 | 0.01 | 0.04 | 0.02 | |
Graham Net | -4.41K | -4.69K | -5.91K | -5.31K | -5.14K | |
Working capital | 164.76B | 167B | 181.87B | 250.32B | 254.14B | |
Tangible asset value | 347.61B | 321.58B | 200.59B | 279.95B | 326.03B | |
Net current asset value | -294.97B | -311.03B | -558.5B | -448.64B | -399.97B | |
Invested capital | 1.01 | 1.48 | 2.01 | 1.32 | 1.2 | |
Average receivables | 411.37B | 390.76B | 430.1B | 465.46B | 498.87B | |
Average payables | 297.49B | 276.32B | 248.52B | 234.93B | 241.25B | |
Average inventory | 435.22B | 443.73B | 386.01B | 333.3B | 357.32B | |
Days sales outstanding | 92.93 | 106.31 | 149.67 | 147.68 | 141.15 | |
Days payables outstanding | 87.8 | 84.68 | 91.73 | 89.18 | 84.21 | |
Days of inventory on hand | 133.78 | 143.69 | 127.73 | 128.85 | 127.65 | |
Receivables turnover | 3.93 | 3.43 | 2.44 | 2.47 | 2.59 | |
Payables turnover | 4.16 | 4.31 | 3.98 | 4.09 | 4.33 | |
Inventory turnover | 2.73 | 2.54 | 2.86 | 2.83 | 2.86 | |
ROE | 0.11 | 0.04 | 0.04 | 0.17 | 0.1 | |
Capex per share | -418.35 | -436.03 | -386.76 | -303.35 | -413.63 |
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q3
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 2.33K | 2.69K | 1.97K | 1.14K | 2.62K | |
Net income per share | 39.18 | 115.68 | 36.96 | -946.25 | 184.78 | |
Operating cash flow per share | -285.59 | 709.19 | -392.51 | -145.1 | -41.76 | |
Free cash flow per share | -391.68 | 568.88 | -488.56 | -248.29 | -150.39 | |
Cash per share | 699.93 | 853.43 | 747.24 | 805.61 | 832.28 | |
Book value per share | 2.68K | 2.85K | 2.91K | 1.97K | 2.1K | |
Tangible book value per share | 2.01K | 2.15K | 2.22K | 1.29K | 1.41K | |
Share holders equity per share | 2.68K | 2.85K | 2.91K | 1.97K | 2.1K | |
Interest debt per share | 3.97K | 3.44K | 3.91K | 5.58K | 5.82K | |
Market cap | 581.71B | 502.29B | 589.79B | 474.34B | 417.88B | |
Enterprise value | 1062.08B | 897.03B | 1069.84B | 1201.4B | 1160.68B | |
P/E ratio | 24.53 | 7.17 | 26.3 | -0.83 | 3.74 | |
Price to sales ratio | 1.65 | 1.24 | 1.98 | 2.76 | 1.05 | |
POCF ratio | -13.46 | 4.68 | -9.91 | -21.61 | -66.11 | |
PFCF ratio | -9.82 | 5.84 | -7.96 | -12.63 | -18.36 | |
P/B Ratio | 1.43 | 1.16 | 1.34 | 1.59 | 1.31 | |
PTB ratio | 1.43 | 1.16 | 1.34 | 1.59 | 1.31 | |
EV to sales | 3.02 | 2.21 | 3.58 | 6.99 | 2.93 | |
Enterprise value over EBITDA | 21.78 | 27.59 | 30.91 | -8.23 | 15.9 | |
EV to operating cash flow | -24.58 | 8.36 | -17.97 | -54.72 | -183.62 | |
EV to free cash flow | -17.92 | 10.42 | -14.44 | -31.98 | -50.99 | |
Earnings yield | 0.01 | 0.03 | 0.01 | -0.3 | 0.07 | |
Free cash flow yield | -0.1 | 0.17 | -0.13 | -0.08 | -0.05 | |
Debt to equity | 1.43 | 1.2 | 1.33 | 2.83 | 2.72 | |
Debt to assets | 0.3 | 0.27 | 0.3 | 0.41 | 0.41 | |
Net debt to EBITDA | 9.85 | 12.14 | 13.87 | -4.98 | 10.18 | |
Current ratio | 1.29 | 1.31 | 1.3 | 1.1 | 1.1 | |
Interest coverage | 1.71 | 15.36 | 1.81 | -542.35 | 3.83 | |
Income quality | -3.37 | 8.57 | -4.68 | 0.13 | -0.15 | |
Dividend Yield | 0.01 | 0 | 0.01 | 0 | 0.02 | |
Payout ratio | 1.03 | 0 | 1.36 | 0 | 0.27 | |
Sales general and administrative to revenue | 0.14 | 0.16 | 0.16 | 0.31 | 0.13 | |
Research and developement to revenue | 0.03 | 0.03 | 0.02 | 0.05 | 0.02 | |
Intangibles to total assets | 0.06 | 0.07 | 0.07 | 0.06 | 0.06 | |
Capex to operating cash flow | 0.37 | -0.2 | 0.24 | 0.71 | 2.6 | |
Capex to revenue | -0.05 | -0.05 | -0.05 | -0.09 | -0.04 | |
Capex to depreciation | -0.92 | -1.12 | -0.86 | -0.9 | -0.92 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 1.54K | 2.72K | 1.56K | 6.48K | 2.96K | |
ROIC | 0.02 | 0.02 | 0 | -0.11 | 0.03 | |
Return on tangible assets | 0 | 0.01 | 0 | -0.07 | 0.01 | |
Graham Net | -5.45K | -5.14K | -5.32K | -6.5K | -6.46K | |
Working capital | 246.83B | 254.14B | 259.41B | 102.11B | 107.21B | |
Tangible asset value | 304.04B | 326.03B | 337.17B | 195.68B | 212.95B | |
Net current asset value | -416.51B | -399.97B | -394.63B | -559.67B | -532.9B | |
Invested capital | 1.43 | 1.2 | 1.33 | 2.83 | 2.72 | |
Average receivables | 499.53B | 518.84B | 521.07B | 529.04B | 545.03B | |
Average payables | 224.54B | 237.04B | 232.56B | 219.76B | 221.78B | |
Average inventory | 400.46B | 390.35B | 400.16B | 430.06B | 446.11B | |
Days sales outstanding | 131.57 | 115.82 | 156.49 | 282.33 | 125.11 | |
Days payables outstanding | 75.51 | 67.65 | 81.68 | 70.27 | 68.59 | |
Days of inventory on hand | 135.11 | 102.54 | 159.52 | 137.78 | 141.43 | |
Receivables turnover | 0.68 | 0.78 | 0.58 | 0.32 | 0.72 | |
Payables turnover | 1.19 | 1.33 | 1.1 | 1.28 | 1.31 | |
Inventory turnover | 0.67 | 0.88 | 0.56 | 0.65 | 0.64 | |
ROE | 0.01 | 0.04 | 0.01 | -0.48 | 0.09 | |
Capex per share | -106.09 | -140.31 | -96.06 | -103.19 | -108.63 |
7013.T Frequently Asked Questions
What is IHI Corporation stock symbol ?
IHI Corporation is a JP stock and trading under the symbol 7013.T
What is IHI Corporation stock quote today ?
IHI Corporation stock price is $3772 today.
Is IHI Corporation stock public?
Yes, IHI Corporation is a publicly traded company.